Cytofluorometric characteristics of molecular subtypes of breast cancer

Cytofluorometric characteristics of molecular subtypes of breast cancer

The paper deals with the results of a study assessing the specific data of laser DNA-flow cytofluorometry and the level of mutant p53 in different histogenetic subtypes.

Bibliographic Details
Main Authors:	L. K. Tsoi, V. N. Bogatyrev, I. V. Vysotskaya, V. P. Letyagin, E. A. Kim
Format:	Article
Language:	Russian
Published:	ABV-press 2014-08-01
Series:	Опухоли женской репродуктивной системы
Subjects:	рак молочной железы лазерная днк-проточная цитофлуорометрия факторы прогноза р53 мутантного типа гистогенетическая классификация
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/267

Similar Items

The clinical value of p53 and the parameters of DNA-flow cytofluorometry in combination with clinical and morphological predictors in breast cancer
by: L. K. Tsoi, et al.
Published: (2014-08-01)

Current standards for the treatment of metastatic breast cancer (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

Current standards for primary breast cancer treatment (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

PREDICTIVE VALUE OF MOLECULAR PARAMETERS IN PATIENTS WITH BASAL-LIKE TRIPL-NEGATIVE BREAST CANCER
by: О. D. Bragina, et al.
Published: (2016-02-01)

SPINAL METASTASES IN BREAST CANCER PATIENTS. PROGNOSTIC FACTORS
by: М. D. Aliev, et al.
Published: (2016-02-01)

SURGICAL RESECTION OF THE PRIMARY TUMOR IN COMBINATION TREATMENT OF PATIENTS WITH STAGE IV BREAST CANCE
by: A. D. Zikiryahodjaev, et al.
Published: (2016-04-01)

THE ROLE OF GATA3, FOXA1, ELF5 TRANSCRIPTION FACTORS IN THE PATHOGENESIS AND PROGNOSIS OF BREAST CANCER
by: D. V. Vasilchenko, et al.
Published: (2020-07-01)

MICROARRAY ANALYSIS OF DNA COPY NUMBER ABERRATION IN BREAST TUMOR: CORRELATION WITH THE EFFICACY OF NEOADJUVANT CHEMOTHERAPY
by: N. V. Litviakov, et al.
Published: (2016-02-01)

Predicting the site of distant metastases in breast cancer
by: E. S. Grigoryeva, et al.
Published: (2023-02-01)

ANDROGEN RECEPTORS AS A FACTOR OF PROGNOSIS IN VARIOUS MOLECULAR-BIOLOGICAL SUBTYPES OF BREAST CANCER
by: D. A. Ryabchikov, et al.
Published: (2017-07-01)

RADIATION THERAPY OF BREAST CANCER WITH ACCOUNT PROGNOSTIC FACTORS
by: K. A. Simonov, et al.
Published: (2016-02-01)

Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer
by: O. O. Gordeeva, et al.
Published: (2020-11-01)

THE COMPLEX OF INFORMATIVE IMMUNOLOGICAL PARAMETERS FOR BREAST CANCER OUTCOME PROGNOSIS
by: M. N. Stakheyeva, et al.
Published: (2015-06-01)

Possibilities of investigating intratumoral lymphocyte subpopulations by flow cytometry of tumor core biopsy specimens in patients with breast cancer
by: F. A. Shamilov, et al.
Published: (2014-07-01)

Prognostic factors in T3–Т4N0M0 breast cancer
by: I. V. Vysotskaya, et al.
Published: (2014-08-01)

Sakharnyy diabet tipa 2 i ozhirenie kak faktory vysokogo riska razvitiya raka mo.yuchnoy zhelezy
by: E Ledneva, et al.
Published: (2003-12-01)

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
by: E. N. Imyanitov, et al.
Published: (2017-12-01)

ASSESSMENT OF PROGNOSTIC FACTORS CONSIDERING THE VOLUME OF SKELETAL METASTASIS IN PATIENTS WITH DISSEMINATED PROSTATE CANCER
by: N. E. Kosyh, et al.
Published: (2017-03-01)

SURGICAL TREATMENT OF BREAST CANCER: FROM THE CONCEPT OF ERADICATION TO AESTHETIC SURGERY
by: I. K. Vorotnikov, et al.
Published: (2018-08-01)

GLAD-PCR assay of DNA methylation sites in regulatory regions of some tumor-suppressor genes in breast cancer
by: N. A. Smetannikova, et al.
Published: (2022-01-01)

PREDICTORS OF A LOCAL RECURRENCE AFTER ORGAN-PRESERVING TREATMENT FOR EARLY BREAST CANCER: STATE-OF-THE-ART
by: N. R. Molodikova, et al.
Published: (2014-09-01)

Present and future of breast cancer anti-Her-2-therapy
by: V. P. Letyagin
Published: (2014-07-01)

Current feasibility of endocrine therapy for breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

CURRENT POTENTIALITIES OF THERAPY FOR FIBROCYSTIC DISEASE
by: I. V. Vysotskaya
Published: (2014-09-01)

Molecular genetic predictors of metastatic lesions of regional lymph nodes in patients with breast cancer
by: V. V. Rodionov, et al.
Published: (2021-10-01)

Subtypes of breast cancer
by: D. D. Pak, et al.
Published: (2014-07-01)

THE ROLE OF AUTOPHAGY AND ANGIOGENESIS IN COLORECTAL CANCER
by: K. V. Rachkovsky, et al.
Published: (2017-12-01)

Evaluation of the scientific results of the study entitled “Opportunities for surgical treatment of patients with stage IV breast cancer” performed by Russian Society of Oncomammologists (RSOM)
by: A. A. Bozhok, et al.
Published: (2017-02-01)

ONCOPLASTIC RESECTION OF MAMMAR Y GLAND WITH SIMULTANEOUS RECONSTRUCTION WITH LOCA TISSUES (USAGE OF LOWER GLANDULAR – TYPE SPAIR BY D. HAMMOND AND ST-INVERSE METHOD)
by: A. D. Zikiryakhodzhayev, et al.
Published: (2016-03-01)

Problems in the treatment of dyshormonal breast hyperplasia: current aspects
by: E. A. Sukhareva, et al.
Published: (2014-08-01)

Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005)
by: V P Letyagin, et al.
Published: (2005-09-01)

MOLECULAR BIOLOGICAL FACTORS IN THE PREDICTION OF PROSTATE CANCER
by: S. V. Vtorushin, et al.
Published: (2017-03-01)

PROGNOSTIC ROLE OF MOLECULAR SUBTYPES OF COLON CANCER. A CURRENT VIEW ON THE PROBLEM
by: L. E. Sinyansky, et al.
Published: (2021-06-01)

Atypical hyperplasias of the breast
by: I. V. Vysotskaya, et al.
Published: (2015-11-01)

EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
by: S. G. Smirnova, et al.
Published: (2020-09-01)

Comparative analysis of the long-term results of treatment in patients with Stages I-IIa breast cancer in relation to major prognostic factors
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Lymphocyte subpopulations of bone marrow of breast cancer patients
by: T. A. Grigorieva, et al.
Published: (2015-07-01)

Current molecular genetic markers of breast cancer
by: N. V. Apanovich, et al.
Published: (2014-07-01)

Reconstructive plastic operations in the treatment of patients with breast cancer
by: V. P. Letyagin, et al.
Published: (2014-07-01)

Practical guidelines for drug correction of diffuse dyshormonal dysplasia of the breast
by: I. V. Vysotskaya, et al.
Published: (2014-07-01)